Forward PE Ratio: 44.80
The forward PE ratio is 44.80 as of Thursday, July 9, 2026.
Forward PE Ratio (44.80) = Close Price ($397.76) / Consensus Forward EPS ($8.85)
HUM Forward PE Ratio Metrics
FORWARD PE RATIO
44.80
HUM Competitors' Forward PE Ratio
Humana Inc.
Market Cap
$47.76B
Forward PE Ratio
44.80
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Humana Inc. (HUM) | $47.76B | 44.80 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.06B | 37.91 |
| Edwards Lifesciences Corporation (EW)vs › | $52.59B | 31.10 |
| Becton, Dickinson and Company (BDX)vs › | $54.65B | 11.96 |
| Cardinal Health, Inc. (CAH)vs › | $54.75B | 22.02 |
| Agilent Technologies, Inc. (A)vs › | $37.73B | 21.31 |
| Cencora, Inc. (COR)vs › | $58.85B | 17.41 |
| IQVIA Holdings Inc. (IQV)vs › | $34.88B | 15.90 |
| Medline Inc. (MDLN)vs › | $34.54B | 26.62 |
| Centene Corp. (CNC)vs › | $33.38B | 19.16 |
Trailing vs Forward
Trailing P/E
42.4
reported TTM EPS
Forward P/E
44.8
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $8.85 implies -5.3% EPS decline vs the reported trailing $9.35.
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $397.76 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $8.85 | $8.27 – $9.17 | 15 | 45.0x |
| 2027-12-31 | $15.84 | $13.51 – $19.05 | 15 | 25.1x |
| 2028-12-31 | $26.34 | $20.04 – $32.21 | 7 | 15.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Forward PE Ratio FAQ
- What is the forward PE ratio for Humana Inc. (HUM)?
- The forward PE ratio for HUM stock is 44.80.
Related Metrics
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin